![Martha Rook](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martha Rook
Chief Operating Officer at
DELCATH SYSTEMS, INC.
Net worth: 82 607 $ as of 2026-05-30
Profile
Martha S.
Rook is Chief Operating Officer at Delcath Systems, Inc. since 2024.
Former roles include Secretary & Director at Alliance for Regenerative Medicine, VP, Head-Gene Editing & Novel Modalities at EMD Millipore Corp.
from 2016 to 2018, Chief Technical Operations Officer at Sigilon Therapeutics, Inc. from 2021 to 2022, and Chief Technical Operations Officer at Insitro, Inc. from 2022 to 2024.
Education includes undergraduate studies at Texas A&M University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-15 | 7,663 ( 0.02% ) | 82 607 $ | 2026-05-30 |
Martha Rook active positions
| Companies | Position | Start |
|---|---|---|
| DELCATH SYSTEMS, INC. | Chief Operating Officer | 2024-03-17 |
Former positions of Martha Rook
| Companies | Position | End |
|---|---|---|
Insitro, Inc.
 Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Chief Tech/Sci/R&D Officer | 2024-02-29 |
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-03-06 |
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and production of biotechnology & pharmaceutical drug therapies | Corporate Officer/Principal | 2017-12-31 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Board Member | - |
Training of Martha Rook
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
41
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and production of biotechnology & pharmaceutical drug therapies | Commercial Services |
Delcath Systems, Inc.
 Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic treatments for chronic diseases | Health Technology |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Health Technology |
- Stock Market
- Insiders
- Martha Rook
